151 related articles for article (PubMed ID: 1305422)
1. Anti-GM3-lactam monoclonal antibodies of the IgG type recognize natural GM3-ganglioside lactone but not GM3-ganglioside.
Ding K; Rosén A; Ray AK; Magnusson G
Glycoconj J; 1992 Dec; 9(6):303-6. PubMed ID: 1305422
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of an anti-idiotype monoclonal antibody related to GM3(NeuGc) ganglioside.
Rodríguez M; Llanes L; Pérez A; Pérez R; Vázquez AM
Hybrid Hybridomics; 2003 Oct; 22(5):307-14. PubMed ID: 14678648
[TBL] [Abstract][Full Text] [Related]
3. Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.
Yamamoto S; Yamamoto T; Saxton RE; Hoon DS; Irie RF
J Natl Cancer Inst; 1990 Nov; 82(22):1757-60. PubMed ID: 1700134
[TBL] [Abstract][Full Text] [Related]
4. Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen.
Nores GA; Dohi T; Taniguchi M; Hakomori S
J Immunol; 1987 Nov; 139(9):3171-6. PubMed ID: 3668254
[TBL] [Abstract][Full Text] [Related]
5. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.
Dohi T; Nores G; Hakomori S
Cancer Res; 1988 Oct; 48(20):5680-5. PubMed ID: 3167827
[TBL] [Abstract][Full Text] [Related]
6. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors.
Carr A; Mullet A; Mazorra Z; Vázquez AM; Alfonso M; Mesa C; Rengifo E; Pérez R; Fernández LE
Hybridoma; 2000 Jun; 19(3):241-7. PubMed ID: 10952412
[TBL] [Abstract][Full Text] [Related]
7. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
[TBL] [Abstract][Full Text] [Related]
8. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
9. Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.
Park JE; Wu DY; Prendes M; Lu SX; Ragupathi G; Schrantz N; Chapman PB
Immunology; 2008 Jan; 123(1):145-55. PubMed ID: 18154620
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice.
He D; Fan X; Liu B; Tian Y; Zhang X; Kang L; Tai Y; Liu S; Wang Q; Li Q; Cai J
Sci Rep; 2018 Feb; 8(1):2561. PubMed ID: 29416099
[TBL] [Abstract][Full Text] [Related]
11. Preparation and properties of antibodies to GD3 and GM1 gangliosides.
Kundu SK; Marcus DM; Veh RW
J Neurochem; 1980 Jan; 34(1):184-8. PubMed ID: 6778957
[TBL] [Abstract][Full Text] [Related]
12. Engineering the binding site of an antibody against N-glycolyl GM3: from functional mapping to novel anti-ganglioside specificities.
Rojas G; Pupo A; Gómez S; Krengel U; Moreno E
ACS Chem Biol; 2013 Feb; 8(2):376-86. PubMed ID: 23138862
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a novel ether-bridged GM3-lactone analogue as a target for an antibody-based cancer therapy.
Tietze LF; Keim H; Janssen CO; Tappertzhofen C; Olschimke J
Chemistry; 2000 Aug; 6(15):2801-8. PubMed ID: 10985728
[TBL] [Abstract][Full Text] [Related]
16. Insights into the immunogenetic basis of two ganglioside-associated idiotypic networks.
Rodríguez M; Roque-Navarro L; López-Requena A; Moreno E; Mateo de Acosta C; Pérez R; María Vázquez A
Immunobiology; 2007; 212(1):57-70. PubMed ID: 17270710
[TBL] [Abstract][Full Text] [Related]
17. Cryoprecipitation of an anti-Pr2 monoclonal IgM cold agglutinin in the presence of GM3 ganglioside.
Yeni P; Harpin ML; Habibi B; Billecocq A; Morelec MJ; Clauvel JP; Danon F; Baumann N; Brouet JC
J Clin Invest; 1984 Oct; 74(4):1165-72. PubMed ID: 6480822
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against ganglioside GM3 represent a portion of anti-lymphocyte antibodies in AIDS patients.
Griggi T; Bauer R; Garofalo T; Kukel S; Lenti L; Massetti AP; Müller C; Sorice M; Pontieri GM
Scand J Immunol; 1994 Jul; 40(1):77-82. PubMed ID: 7913247
[TBL] [Abstract][Full Text] [Related]
19. [GM3 ganglioside as melanoma specific antigen and its biological function].
Hirabayashi Y; Taniguchi M
Hum Cell; 1989 Mar; 2(1):63-9. PubMed ID: 2535260
[TBL] [Abstract][Full Text] [Related]
20. Key role of a structural water molecule for the specificity of 14F7-An antitumor antibody targeting the NeuGc GM3 ganglioside.
Bjerregaard-Andersen K; Abraha F; Johannesen H; Oscarson S; Moreno E; Krengel U
Glycobiology; 2021 Dec; 31(11):1500-1509. PubMed ID: 34735569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
